Last reviewed · How we verify
NCT04974034
Movement Disorders Analysis Using a Deep Learning Approach
trial in Bradykinesia in 50 participants. Completed in 31 December 2020.
18 November 2020
Quick facts
| Lead sponsor | Hospital Avicenne |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 June 2019 |
| Primary completion | 18 November 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across France |
Conditions studied
- Bradykinesia — all drugs for Bradykinesia →
- Parkinson Disease — all drugs for Parkinson Disease →
- Hypokinesia — all drugs for Hypokinesia →
- Akinesia — all drugs for Akinesia →
Sponsor
Hospital Avicenne
Who can join
18 and older, any sex, with Bradykinesia or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bradykinesia is a key parkinsonian feature yet subjectively assessed by the MDS-UPDRS score, making reproducible measurements and follow-up challenging. In a Movement Disorder Unit, the investigators acquired a large database of videos showing parkinsonian patients performing Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III protocols. Using a Deep Learning approach on these videos, the investigators aimed to develop a tool to compute an objective score of bradykinesia from the three upper limb tests described in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Video-Based Automated Assessment of Movement Parameters Consistent with MDS-UPDRS III in Parkinson's Disease.
Vignoud G, Desjardins C, Salardaine Q, Mongin M, et al · · 2022 · cited 19× · PMID 35964204 · DOI 10.3233/jpd-223445
Verify or expand the search:
- PubMed search for NCT04974034
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bradykinesia
Currently open trials in the same condition.
- NCT07397377 — prTMS as an Intervention for Bradykinesia in Parkinson's Disease · NA · recruiting
Other Hospital Avicenne trials
Trials by the same sponsor.
- NCT03806959 — Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy · NA · completed
- NCT04948684 — Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism · completed
- NCT03254472 — Big Data Analysis of the Use of bIomarkers Concentration · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04974034 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Avicenne
- Last refreshed: 23 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04974034.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing